Trusted advisor with a market leading restructuring and insolvency position in Asia
The A&M Asia restructuring team provides a one stop solution for companies and investors in distressed situations. We have a proven track record of providing solutions that maximize value for all stakeholders in challenging situations.
We act as the lead Financial Advisor driving the process to help lenders and borrowers find solutions to capital structure challenges ranging from simple amendments through to the most complex changes to capital structures involving equity raises, M&A activity, changes of control and debt-to-equity swaps. Learn more.
We support clients’ refinancing efforts through a spectrum of liability management options that enhance market confidence, achieve deleveraging efficiency, defer near-term maturities, amend covenants. Learn more.
Our restructuring professionals can act in the capacity of Scheme Administrator to support transaction implementation, Interim Management to develop and drive the turnaround plan, or as Directors to provide governance support post restructuring. Learn more.
We produce contingency plans so that, where an insolvency appointment becomes necessary or unavoidable, plans are in place to efficiently deliver a restructuring or, where this is not possible, preserve and maximize value. Learn more
Australia's venture capital may be stifled by a new tax on superannuation over $3M, clashing with policies to boost early-stage ventures via tax concessions.
A change in the German tax law obliges (Private Equity) Funds that are resident outside of Germany to file German partnership tax returns in case they have more than one German investor.
In a recent article, A&M Life Sciences experts discuss The Drug Supply Chain Security Act and how well-intentioned regulations may be straining the very system they’re meant to safeguard.
Your browser version isn’t supported. For optimal browsing experience, please use Chrome, Firefox, Safari, or Edge. Thank you.